BeiGene is building a flagship U.S. biologics manufacturing and R&D facility at the Princeton West Innovation Campus in Hopewell, N.J. This new facility will provide state-of-the art, clinical- and commercial-stage biologics manufacturing and clinical R&D center, which complement BeiGene’s existing capabilities around the world.
The Company is committed to making a significant investment in New Jersey – beyond construction and staffing – to ensure it is a responsible and positive force in the community.
Learn more about our facility and community impact below.
